Recursion Pharmaceuticals, Inc. RXRX Business Segments — Platform
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Recursion Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept rxrx:PlatformFeeExpense.
The official record: Recursion Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Recursion Pharmaceuticals, Inc.'s business segments — platform.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Recursion Pharmaceuticals, Inc.'s business segments — platform?
- Recursion Pharmaceuticals, Inc. (RXRX) reported business segments — platform of $7.61M in Q1 2026.
- How has Recursion Pharmaceuticals, Inc.'s business segments — platform changed year-over-year?
- Recursion Pharmaceuticals, Inc.'s business segments — platform decreased by 13.1% year-over-year, from $8.77M to $7.61M.
- What is the long-term trend for Recursion Pharmaceuticals, Inc.'s business segments — platform?
- Over 3 years (2022 to 2025), Recursion Pharmaceuticals, Inc.'s business segments — platform has grown at a 116.9% compound annual growth rate (CAGR), from $4.82M to $49.21M.
- What does business segments — platform mean?
- Represents the operational expenditures dedicated to maintaining, upgrading, and scaling the company's proprietary technology infrastructure or core platform. This investment is critical for companies relying on data-driven or automated processes to maintain a competitive technological advantage.